Abstract

Although considered effective treatment for many yeast fungi, the therapeutic efficacy of the echinocandin class of antifungals for invasive aspergillosis (IA) is limited. Recent studies suggest intense kinase- and phosphatase-mediated echinocandin adaptation in A. fumigatus. To identify A. fumigatus protein kinases required for survival under echinocandin stress, we employed CRISPR/Cas9-mediated gene targeting to generate a protein kinase disruption mutant library in a wild type genetic background. Cell wall and echinocandin stress screening of the 118 disruption mutants comprising the library identified only five protein kinase disruption mutants displaying greater than 4-fold decreased echinocandin minimum effective concentrations (MEC) compared to the parental strain. Two of these mutated genes, the previously uncharacterized A. fumigatus sepL and sidB genes, were predicted to encode protein kinases functioning as core components of the Septation Initiation Network (SIN), a tripartite kinase cascade that is necessary for septation in fungi. As the A. fumigatus SIN is completely uncharacterized, we sought to explore these network components as effectors of echinocandin stress survival. Our data show that mutation of any single SIN kinase gene caused complete loss of hyphal septation and increased susceptibility to cell wall stress, as well as widespread hyphal damage and loss of viability in response to echinocandin stress. Strikingly, mutation of each SIN kinase gene also resulted in a profound loss of virulence characterized by lack of tissue invasive growth. Through the deletion of multiple novel regulators of hyphal septation, we show that the non-invasive growth phenotype is not SIN-kinase dependent, but likely due to hyphal septation deficiency. Finally, we also find that echinocandin therapy is highly effective at eliminating residual tissue burden in mice infected with an aseptate strain of A. fumigatus. Together, our findings suggest that inhibitors of septation could enhance echinocandin-mediated killing while simultaneously limiting the invasive potential of A. fumigatus hyphae.

Highlights

  • Aspergillus fumigatus is among the most common causes of human invasive fungal infections in immunocompromised individuals, including solid organ transplant recipients, those undergoing hematopoietic stem cell transplant, and patients receiving highly immunosuppressive chemotherapies [1,2,3]

  • Aspergillus fumigatus is a ubiquitous fungal pathogen and the major causative agent of a life-threatening infection known as invasive aspergillosis (IA)

  • We sought to identify A. fumigatus genes required for fungal survival under echinocandin stress by generating and screening an A. fumigatus mutant library composed of disruptions in genes encoding putative protein kinases

Read more

Summary

Introduction

Aspergillus fumigatus is among the most common causes of human invasive fungal infections in immunocompromised individuals, including solid organ transplant recipients, those undergoing hematopoietic stem cell transplant, and patients receiving highly immunosuppressive chemotherapies [1,2,3]. In the immune compromised host, these conidia undergo a process of germination characterized by an initial phase of isotropic swelling followed by a switch to highly polarized growth leading to the formation of a germ tube These germ tubes continue to extend through focused growth at the cell apex to generate the invasive hyphal forms that can invade surrounding tissue in search of nutrients, eventually reaching the pulmonary microvasculature system to disseminate [6]. Decades of research have focused on A. fumigatus conidial adherence to and nutrient utilization in the host lung environment, as well as on the cellular and molecular processes essential for subsequent hyphal formation and invasion, our understanding of these processes remain incomplete

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call